1. Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer

   • Jee Hyun Ahn
   • Jung Min Park
   • Hyung Seok Park

   Editorial 23 November 2022 Pages: 405 - 412

   

2. Circadian rhythm disrupting behaviours and cancer outcomes in breast cancer survivors: a systematic review

   • Kelly D’cunha
   • Yikyung Park
   • Marina M. Reeves

   Review Open access 23 November 2022 Pages: 413 - 421

   

3. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development

   • Abrar I. Aljohani
   • Michael S. Toss
   • Emad A. Rakha

   Preclinical study Open access 22 November 2022 Pages: 423 - 435

   

4. Overexpression of POU3F2 promotes radioresistance in triple-negative breast cancer via Akt pathway activation

   • Han Zhang
   • Jieling Zheng
   • Guozhu Xie

   Preclinical study 17 February 2023 Pages: 437 - 446

   

5. Effects of preoperative magnetic resonance image on survival rates and surgical planning in breast cancer conservative surgery: randomized controlled trial (BREAST-MRI trial)

   • Bruna Salani Mota
   • Yedda Nunes Reis
   • José Roberto Filassi

   Clinical trial Open access 14 February 2023 Pages: 447 - 461

   

6. Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution

   • Jean-Louis Lacaze
   • Ciprian Chira
   • Florence Dalenc

   Clinical trial 15 February 2023 Pages: 463 - 474

   

7. Does the toxicity of endocrine therapy persist into long-term survivorship?: Patient-reported outcome results from a follow-up study beyond a 10-year-survival

   • Albertini Carmen
   • Oberguggenberger Anne
   • Brunner Christine

   Clinical Trial Open access 23 November 2022 Pages: 475 - 485

   

8. A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)

   • Monica K. Malhotra
   • Shalu Pahuja
   • Shannon Puhalla

   Clinical trial 28 February 2023 Pages: 487 - 498

   

9. Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records

   • Linda Thorén
   • Sara Margolin
   • Jonatan D. Lindh

   Clinical trial Open access 01 March 2023 Pages: 499 - 508

   

10. Estimating the incidence of breast cancer recurrence using administrative data

    • Steven Habbous
    • Andriana Barisic
    • Claire Holloway

    Epidemiology 23 November 2022 Pages: 509 - 522

    

11. Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program

    • Nicholas Gold
    • Rebecca A. G. Christensen
    • Jennifer D. Brooks

    Epidemiology Open access 17 February 2023 Pages: 523 - 533

    

12. Changes in mammographic density and risk of breast cancer among a diverse cohort of women undergoing mammography screening

    • Aimilia Gastounioti
    • Eric A. Cohen
    • Anne Marie McCarthy

    Epidemiology 17 February 2023 Pages: 535 - 544

    

13. Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL

    • M. Thill
    • M.-O. Zahn
    • the OPAL study group

    Epidemiology Open access 18 February 2023 Pages: 545 - 553

    

14. A specific anti-cyclin D1 intrabody represses breast cancer cell proliferation by interrupting the cyclin D1–CDK4 interaction

    • Jialiang Zhao
    • Yan Wu
    • Guiying Li

    Original Laboratory Investigation 19 February 2023 Pages: 555 - 568

    

15. Single-institution outcomes after excision of benign phyllodes tumors: low recurrence risk even with positive margins

    • Zainab Balogun
    • Jennifer G. Steiman
    • Emilia J. Diego

    Original Laboratory Investigation 20 February 2023 Pages: 569 - 572

16. Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature

    • Chiara Rossi
    • Sara Fraticelli
    • Marco Lucioni

    Original Laboratory Investigation Open access 21 February 2023 Pages: 573 - 582

    

17. Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia

    • Qiuyu Liu
    • Nasi Liu
    • Sylvia E. Le Dévédec

    Original Laboratory Investigation Open access 24 February 2023 Pages: 583 - 596

    

18. Mitigating disparities in breast cancer treatment at an academic safety-net hospital

    • Brendin R. Beaulieu-Jones
    • Grant Shewmaker
    • Michael R. Cassidy

    Original Laboratory Investigation 24 February 2023 Pages: 597 - 606

    

19. Effective combination treatments for breast cancer inhibition by FOXM1 inhibitors with other targeted cancer drugs

    • Valeria Sanabria Guillen
    • Yvonne Ziegler
    • Benita S. Katzenellenbogen

    Original Laboratory Investigation 27 February 2023 Pages: 607 - 621

    

20. Metastatic pure invasive lobular breast cancer or metastatic mixed invasive ductal and lobular breast cancer: are they different entities?

    • Kadri Altundag

    Letter to the Editor 28 February 2023 Pages: 623 - 623